Similar Articles |
|
The Motley Fool January 20, 2011 Dan Caplinger |
Value Investing Will Never Be the Same More value-oriented funds are buying traditional growth stocks. |
The Motley Fool January 12, 2012 Dan Caplinger |
An All-or-Nothing 2012 for JPMorgan Chase Let's look at this year's prospects for this company. |
The Motley Fool July 7, 2010 Dan Caplinger |
Party Like It's 1982 Single-digit P/Es are back on major stocks. Even if things are a lot different now than they were in 1982, it's still worth taking a close look at blue-chip stocks. |
The Motley Fool December 15, 2005 Rick Aristotle Munarriz |
3 Stocks to Sell in 2006 Some of 2005's big winners may be in for a rude awakening next year: ExxonMobil... Google... Toll Brothers... |
The Motley Fool February 22, 2007 Brian Lawler |
Dueling Fools: Pfizer Bear It's been a blue chip for years, but that doesn't mean it will stay that way forever. It's inconceivable for Pfizer's market capitalization to be valued at $188 billion four years from now, when its revenues could be 40% lower than they are today. |
The Motley Fool June 29, 2010 Rex Moore |
Microsoft Gives Apple a Noogie Tired of the excitement about Apple, Redmond fires back. |
The Motley Fool October 8, 2010 Jeremy Phillips |
Time to Sell ExxonMobil? Over the past 12 months, ExxonMobil is down 8.1% versus an S&P 500 return of 11.3%. Investors in ExxonMobil are no doubt disappointed with their returns, but is now the time to cut and run? |
The Motley Fool October 26, 2009 Dave Mock |
3 Reasons to Sell United States Oil Today Not everyone is on the buy side. |
The Motley Fool August 30, 2010 Anand Chokkavelu |
How Cheap Is ExxonMobil Stock Right Now? Let's take a look. |
The Motley Fool October 25, 2005 Selena Maranjian |
Is Biggest Best? Even giant companies can be volatile. Don't be complacent with blue chips. It's never smart to look at just one factor for any company. To have the best chance of doing well, you need to study a company closely, evaluating its health and prospects from many angles. |
The Motley Fool October 11, 2004 Roger Nusbaum |
Pfizer: Prognosis Critical This American icon seems destined to lag for the forseeable future. |
The Motley Fool April 23, 2009 Dan Caplinger |
Investments That Don't Stand a Chance An active fund that only seeks to match its benchmark is a waste of your money. If that's all a fund can offer, you're much better off going with the index fund. |
The Motley Fool September 14, 2010 Morgan Housel |
7 Stocks the World's Greatest Hedge Fund Managers Love Follow the leader. |
The Motley Fool September 23, 2010 Rick Aristotle Munarriz |
Throw This Stock Away Shares of AT&T hit a fresh 52-week high, but why? It may be time to get rid of this stock. |
The Motley Fool March 19, 2010 Eric Bleeker |
How Does Apple Become a $300 Billion Company? Apple's become a behemoth. What will it take for the company to keep growing? |
The Motley Fool September 7, 2011 Rick Aristotle Munarriz |
Some Stocks Are Cheap for a Reason Not every stock in the lost decade deserves to be found. |
The Motley Fool February 22, 2007 Ryan Fuhrmann |
Dueling Fools: Pfizer Bull The drug giant has ample firepower. The current company valuation largely ignores Pfizer's upside potential past 2008. |
The Motley Fool October 3, 2011 Rick Aristotle Munarriz |
3 Stock Predictions for the Fourth Quarter Time to dust off the crystal ball and make some stock predictions. |
The Motley Fool November 23, 2005 Nathan Parmelee |
Buy Google? No, Thanks Just how expensive is Google compared with other companies? For those buying shares today, Google would have to grow for another five or 10 years at rates that have never been seen before in order for the investment to make sense. |
The Motley Fool September 2, 2010 Anand Chokkavelu |
Is Pfizer Stock Cheap Right Now? If you find Pfizer's numbers compelling, continue your due diligence. |
The Motley Fool September 25, 2010 Anders Bylund |
How Big Is Apple, Really? Apple's market cap is ginormous, but do the underlying fundamentals match the price tag? |
The Motley Fool April 21, 2008 Brian Lawler |
Pfizer Is Still Floundering Generic competition keeps pounding away at its sales and profits. |
The Motley Fool September 6, 2006 Shannon Zimmerman |
Get Off to a Smart Start Just getting your feet wet with investing? We've got a cheat sheet. |
The Motley Fool August 9, 2010 Alex Dumortier |
Top 5 Banks: Long-Term Buy or Short-Term Sell? Banks are prepared for a slowdown. Are you? |
The Motley Fool February 8, 2006 W.D. Crotty |
Best Blue Chip: ExxonMobil In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: ExxonMobil is the best of this bunch -- and its products fuel the industrialized world. |
The Motley Fool January 26, 2006 |
Dueling Fools: Microsoft Hard times for Mr. Softy? Investors, it is still the leading software company and every inch the bellwether. |
The Motley Fool June 11, 2008 Brian Lawler |
Dueling Fools: Pfizer Bear Is Pfizer ready for a comeback? The bearish opinion is that shares may be down, but the bleeding still isn't over. |
The Motley Fool May 11, 2010 Rick Aristotle Munarriz |
4 Losers That Will Be Winners Here are four stocks from last week's list of 52-week lows that could bounce back quickly: A 123 Systems... ExxonMobil... China Real Estate Info... Novatel Wireless... |
The Motley Fool December 1, 2011 John Grgurich |
Pfizer Losing Lipitor Patent: What Investors Need to Know The patent ends today. |
The Motley Fool November 7, 2011 Dan Caplinger |
Has Pfizer Become the Perfect Stock? The pharma giant still faces the challenge of patent expirations that could outpace its pipeline development. |
The Motley Fool April 29, 2005 Stephen D. Simpson |
ExxonMobil: A Big Oil Slick? Declines in hydrocarbon production hurt first-quarter results and might indicate future troubles. |
The Motley Fool December 17, 2009 Selena Maranjian |
The Stock Market: Not a Popularity Contest Widely held stocks can often underperform their less popular peers. |
The Motley Fool October 4, 2010 Morgan Housel |
5 Stocks the Value Greats Love Here's where you find cheap ideas. |
The Motley Fool May 27, 2008 David Lee Smith |
Are the Rockefellers Right About Exxon? Amid growing concerns about the world's supply of oil having reached an inflection point where it will no longer meet demand, the offspring of ExxonMobil's founder have taken it upon themselves to try to set the company's direction. |